NEW YORK, NY / ACCESSWIRE / October 30, 2024 / Aegis Capital Corp. acted as Sole Bookrunner on a $4.2 Million (IPO) Initial Public Offering for Polyrizon Ltd. (NASDAQ:PLRZ). About Polyrizon Ltd.
Polyrizon Ltd. (the 'Company' or 'PLRZ'), a development stage biotech company specializing in the development of innovative medical device hydrogels, today announced the closing of its underwritten ...